Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-
specific nature, causing harm to non-malignant tissues. Over the past several decades …

Cancer vaccines have emerged as a powerful new tool for cancer immunotherapy.
Adjuvants are vaccine ingredients that enhance the strength, velocity, and duration of the …

Designing and develo** nanomedicine based on the tumor microenvironment (TME) for
effective cancer treatment is highly desirable. In this work, polyvinyl pyrrolidone (PVP) …

Since their initial development, cell membrane-coated nanoparticles (CNPs) have become
increasingly popular in the biomedical field. Despite their inherent versatility and ability to …

Over the past decades, great interest has been given to biomimetic nanoparticles (BNPs)
since the rise of targeted drug delivery systems and biomimetic nanotechnology. Biological …

Immunotherapy has had a profound positive effect on certain types of cancer but has not
improved the outcomes of glioma because of the blood–brain barrier (BBB) and …

Manipulating the tumor immune contexture towards a more active state can result in better
therapeutic outcomes. Here we describe an easily accessible bacterial biomineralization …

Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …

Cell‐membrane‐coated nanoparticles (CCNPs) that integrate the biophysiological
advantages of cell membranes with the multifunctionalities of synthetic materials hold great …

As numerous diseases are associated with increased local inflammation, directing drugs to
the inflamed sites can be a powerful therapeutic strategy. One of the common characteristics …